nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—peripheral nervous system neoplasm	0.425	1	CbGaD
Posaconazole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.055	0.167	CbGbCtD
Posaconazole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.055	0.167	CbGbCtD
Posaconazole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0381	0.116	CbGbCtD
Posaconazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0329	0.1	CbGbCtD
Posaconazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0306	0.0931	CbGbCtD
Posaconazole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0235	0.0714	CbGbCtD
Posaconazole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0219	0.0665	CbGbCtD
Posaconazole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0215	0.0654	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0147	0.0446	CbGbCtD
Posaconazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0141	0.0428	CbGbCtD
Posaconazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0129	0.0392	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00878	0.0267	CbGbCtD
Posaconazole—Itraconazole—ABCB1—peripheral nervous system neoplasm	0.00074	0.625	CrCbGaD
Posaconazole—Ketoconazole—ABCB1—peripheral nervous system neoplasm	0.000443	0.375	CrCbGaD
Posaconazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.12e-05	0.000209	CcSEcCtD
Posaconazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.11e-05	0.000208	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000207	CcSEcCtD
Posaconazole—Rash—Dactinomycin—peripheral nervous system neoplasm	5.08e-05	0.000207	CcSEcCtD
Posaconazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.07e-05	0.000207	CcSEcCtD
Posaconazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000206	CcSEcCtD
Posaconazole—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000205	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.03e-05	0.000205	CcSEcCtD
Posaconazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.03e-05	0.000205	CcSEcCtD
Posaconazole—Fatigue—Etoposide—peripheral nervous system neoplasm	5.02e-05	0.000205	CcSEcCtD
Posaconazole—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000205	CcSEcCtD
Posaconazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000204	CcSEcCtD
Posaconazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000204	CcSEcCtD
Posaconazole—Pain—Etoposide—peripheral nervous system neoplasm	4.98e-05	0.000203	CcSEcCtD
Posaconazole—Constipation—Etoposide—peripheral nervous system neoplasm	4.98e-05	0.000203	CcSEcCtD
Posaconazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000203	CcSEcCtD
Posaconazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000203	CcSEcCtD
Posaconazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000203	CcSEcCtD
Posaconazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000203	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000202	CcSEcCtD
Posaconazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.94e-05	0.000201	CcSEcCtD
Posaconazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.92e-05	0.000201	CcSEcCtD
Posaconazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.0002	CcSEcCtD
Posaconazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000199	CcSEcCtD
Posaconazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000198	CcSEcCtD
Posaconazole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000197	CcSEcCtD
Posaconazole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000197	CcSEcCtD
Posaconazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000196	CcSEcCtD
Posaconazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000196	CcSEcCtD
Posaconazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.8e-05	0.000196	CcSEcCtD
Posaconazole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000196	CcSEcCtD
Posaconazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.78e-05	0.000195	CcSEcCtD
Posaconazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000195	CcSEcCtD
Posaconazole—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000195	CcSEcCtD
Posaconazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.77e-05	0.000194	CcSEcCtD
Posaconazole—Dizziness—Vincristine—peripheral nervous system neoplasm	4.76e-05	0.000194	CcSEcCtD
Posaconazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.75e-05	0.000194	CcSEcCtD
Posaconazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000193	CcSEcCtD
Posaconazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000193	CcSEcCtD
Posaconazole—Rash—Alitretinoin—peripheral nervous system neoplasm	4.71e-05	0.000192	CcSEcCtD
Posaconazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.7e-05	0.000192	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000192	CcSEcCtD
Posaconazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.69e-05	0.000191	CcSEcCtD
Posaconazole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000191	CcSEcCtD
Posaconazole—Headache—Alitretinoin—peripheral nervous system neoplasm	4.68e-05	0.000191	CcSEcCtD
Posaconazole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.00019	CcSEcCtD
Posaconazole—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.00019	CcSEcCtD
Posaconazole—Urticaria—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000189	CcSEcCtD
Posaconazole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000189	CcSEcCtD
Posaconazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000189	CcSEcCtD
Posaconazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000189	CcSEcCtD
Posaconazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000188	CcSEcCtD
Posaconazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.61e-05	0.000188	CcSEcCtD
Posaconazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.61e-05	0.000188	CcSEcCtD
Posaconazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000188	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000188	CcSEcCtD
Posaconazole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000188	CcSEcCtD
Posaconazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000188	CcSEcCtD
Posaconazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000187	CcSEcCtD
Posaconazole—Vomiting—Vincristine—peripheral nervous system neoplasm	4.57e-05	0.000187	CcSEcCtD
Posaconazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.56e-05	0.000186	CcSEcCtD
Posaconazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000186	CcSEcCtD
Posaconazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.54e-05	0.000185	CcSEcCtD
Posaconazole—Rash—Vincristine—peripheral nervous system neoplasm	4.54e-05	0.000185	CcSEcCtD
Posaconazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.53e-05	0.000185	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000185	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000184	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000184	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000184	CcSEcCtD
Posaconazole—Headache—Vincristine—peripheral nervous system neoplasm	4.51e-05	0.000184	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000183	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000182	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000181	CcSEcCtD
Posaconazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.43e-05	0.000181	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.00018	CcSEcCtD
Posaconazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.35e-05	0.000178	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000177	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000177	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000175	CcSEcCtD
Posaconazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.29e-05	0.000175	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000175	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000175	CcSEcCtD
Posaconazole—Nausea—Vincristine—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Posaconazole—Flushing—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000174	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000174	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000174	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.23e-05	0.000173	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000172	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.2e-05	0.000171	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000171	CcSEcCtD
Posaconazole—Asthenia—Etoposide—peripheral nervous system neoplasm	4.18e-05	0.000171	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000171	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00017	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.00017	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000169	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000169	CcSEcCtD
Posaconazole—Chills—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000168	CcSEcCtD
Posaconazole—Pruritus—Etoposide—peripheral nervous system neoplasm	4.12e-05	0.000168	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000168	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000166	CcSEcCtD
Posaconazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.04e-05	0.000165	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000164	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000164	CcSEcCtD
Posaconazole—Rash—Cisplatin—peripheral nervous system neoplasm	4.01e-05	0.000164	CcSEcCtD
Posaconazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.01e-05	0.000164	CcSEcCtD
Posaconazole—Erythema—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000163	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000163	CcSEcCtD
Posaconazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.99e-05	0.000163	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000162	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000162	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000161	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000161	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000161	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.00016	CcSEcCtD
Posaconazole—Back pain—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000158	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000158	CcSEcCtD
Posaconazole—Dizziness—Etoposide—peripheral nervous system neoplasm	3.85e-05	0.000157	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000157	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000157	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000156	CcSEcCtD
Posaconazole—Chills—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000156	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000155	CcSEcCtD
Posaconazole—Nausea—Cisplatin—peripheral nervous system neoplasm	3.78e-05	0.000154	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000154	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000153	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000152	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000152	CcSEcCtD
Posaconazole—Vomiting—Etoposide—peripheral nervous system neoplasm	3.71e-05	0.000151	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000151	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000151	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000151	CcSEcCtD
Posaconazole—Agitation—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.00015	CcSEcCtD
Posaconazole—Rash—Etoposide—peripheral nervous system neoplasm	3.67e-05	0.00015	CcSEcCtD
Posaconazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.67e-05	0.00015	CcSEcCtD
Posaconazole—Headache—Etoposide—peripheral nervous system neoplasm	3.65e-05	0.000149	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.000149	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000148	CcSEcCtD
Posaconazole—Malaise—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000147	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000147	CcSEcCtD
Posaconazole—Syncope—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000146	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000146	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000145	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000144	CcSEcCtD
Posaconazole—Cough—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000143	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000142	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000142	CcSEcCtD
Posaconazole—Nausea—Etoposide—peripheral nervous system neoplasm	3.46e-05	0.000141	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000141	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.00014	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.00014	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000139	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000139	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.000139	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000139	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000139	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000138	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.37e-05	0.000137	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000136	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000136	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000136	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000136	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000135	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000134	CcSEcCtD
Posaconazole—Oedema—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000133	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000133	CcSEcCtD
Posaconazole—Infection—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000132	CcSEcCtD
Posaconazole—Cough—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000132	CcSEcCtD
Posaconazole—Shock—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000131	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000131	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000131	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000131	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.00013	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.00013	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000129	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000129	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000129	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000129	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000129	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000128	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000128	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000127	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.11e-05	0.000127	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000126	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000125	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000124	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000123	CcSEcCtD
Posaconazole—Infection—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000123	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000121	CcSEcCtD
Posaconazole—Shock—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000121	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000121	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.95e-05	0.000121	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.00012	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.94e-05	0.00012	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.00012	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000119	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000119	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000119	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.88e-05	0.000118	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000117	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000116	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000115	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000115	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000115	CcSEcCtD
Posaconazole—Pain—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000114	CcSEcCtD
Posaconazole—Constipation—Epirubicin—peripheral nervous system neoplasm	2.79e-05	0.000114	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000112	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.73e-05	0.000112	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000111	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.00011	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.00011	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.00011	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.67e-05	0.000109	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000109	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000107	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000106	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000106	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000106	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000105	CcSEcCtD
Posaconazole—Pain—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000105	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000105	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000105	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000102	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000101	CcSEcCtD
Posaconazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.41e-05	9.82e-05	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	9.8e-05	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	9.75e-05	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	9.75e-05	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.34e-05	9.56e-05	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.31e-05	9.43e-05	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.24e-05	9.12e-05	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	9.09e-05	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	8.85e-05	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.16e-05	8.82e-05	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	8.73e-05	CcSEcCtD
Posaconazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.08e-05	8.48e-05	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	8.44e-05	CcSEcCtD
Posaconazole—Rash—Epirubicin—peripheral nervous system neoplasm	2.06e-05	8.41e-05	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.06e-05	8.4e-05	CcSEcCtD
Posaconazole—Headache—Epirubicin—peripheral nervous system neoplasm	2.05e-05	8.35e-05	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2e-05	8.16e-05	CcSEcCtD
Posaconazole—Nausea—Epirubicin—peripheral nervous system neoplasm	1.94e-05	7.92e-05	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.92e-05	7.84e-05	CcSEcCtD
Posaconazole—Rash—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	7.78e-05	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	7.77e-05	CcSEcCtD
Posaconazole—Headache—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	7.73e-05	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.8e-05	7.33e-05	CcSEcCtD
